Media
XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development
UCB Partners with Ailux Biologics, a Division of XtalPi, on Biologics Al Platform
Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform
Official Press Release: Introducing Ailux Biologics by XtalPi
Ailux Announces Posters at American College of Rheumatology (ACR) Convergence 2025
PEGS Boston 2025
Antibody Engineering & Therapeutics 2024 USA
PEGS Europe 2024